Benadryl (diphenhydramine) isn’t just an allergy pill that makes you sleepy. It’s a powerful anticholinergic drug that crosses into your brain, interferes with a key neurotransmitter involved in memory and cognition, and carries enough risk that major medical organizations recommend older adults avoid it entirely. For occasional use in a healthy adult, it’s not dangerous. But the reasons it’s considered problematic go well beyond drowsiness.
It Doesn’t Stay Out of Your Brain
Benadryl is a first-generation antihistamine, which means it was developed before scientists figured out how to make allergy drugs that target only the body and not the brain. Diphenhydramine easily crosses the blood-brain barrier, where it blocks histamine receptors in the central nervous system. That’s what causes the heavy sedation people feel, and it’s also what suppresses coughs. But the drug doesn’t stop there.
Because histamine receptors in the brain are structurally similar to receptors for acetylcholine, a neurotransmitter critical for memory, learning, and muscle control, Benadryl blocks those too. This anticholinergic effect is responsible for most of the drug’s problematic side effects: dry mouth, blurred vision (especially for close-up objects), constipation, elevated heart rate, confusion, and difficulty urinating. These aren’t rare reactions. They’re predictable consequences of how the drug works throughout your body.
Cumulative Use Is Linked to Dementia
The most alarming concern with Benadryl is what happens with repeated use over time. A large prospective study found that higher cumulative exposure to strong anticholinergic drugs like diphenhydramine is associated with an increased risk of dementia. This isn’t about taking one dose when you can’t sleep. It’s about the pattern many people fall into: reaching for Benadryl regularly as a sleep aid or allergy remedy over months or years.
The American Geriatrics Society lists diphenhydramine as a drug to avoid in adults 65 and older through its Beers Criteria, a widely used set of guidelines for medication safety. The recommendation is rated “strong” based on moderate-quality evidence. The rationale: the drug is highly anticholinergic, its clearance slows with age, and cumulative anticholinergic exposure raises the risk of falls, delirium, and dementia. Notably, the guidelines add that even “younger adults” face increased risk from cumulative anticholinergic burden, not just the elderly.
The only exception the guidelines carve out is for acute treatment of a severe allergic reaction, where the benefits clearly outweigh the risks.
It’s a Poor Sleep Aid
Many people use Benadryl primarily for sleep, not allergies. It does make you fall asleep faster, but the quality of that sleep is compromised. Diphenhydramine significantly delays the onset of REM sleep and reduces the overall percentage of time you spend in REM, the sleep stage most important for memory consolidation and emotional regulation. You may sleep longer but wake up feeling less restored.
The next-day hangover is real. Studies in healthy young adults show sedative effects lasting roughly 6.5 hours after a dose, meaning a pill taken at bedtime can still impair your alertness and reaction time the following morning. One study found significant reductions in psychomotor performance the day after taking diphenhydramine.
Perhaps most telling: tolerance to the sedative effect develops within three to four days of regular use. By day four, drowsiness and performance declines tend to reverse. So if you’re taking it nightly, the sleep benefit fades quickly while the anticholinergic effects on your body and brain continue.
Overdose Risk Is Higher Than People Expect
Because Benadryl is sold over the counter and marketed for common conditions, many people assume it has a wide safety margin. It doesn’t. Moderate toxicity symptoms, including agitation, confusion, hallucinations, and heart rhythm changes, have been observed at doses as low as 300 milligrams. That’s only six standard 50-mg tablets. Severe toxicity, including delirium, seizures, psychosis, coma, and death, can occur at doses of 1 gram or more (twenty standard tablets).
The cardiac effects are particularly dangerous. At toxic levels, diphenhydramine blocks potassium channels in the heart that control its electrical rhythm. This can widen the QRS complex on an EKG, prolong the QT interval, and set the stage for a potentially fatal heart rhythm called torsades de pointes. These aren’t theoretical risks; they’re documented consequences of doses that aren’t far above what someone might take if they double up because the first dose “didn’t work.”
Children Are Especially Vulnerable
The FDA warns that children under 2 should never receive any cough and cold product containing an antihistamine or decongestant, citing the risk of convulsions, rapid heart rate, and death. Manufacturers voluntarily relabeled these products to extend the warning to children under 4.
The danger for children often comes from compounding errors: giving doses too frequently, using more than the recommended amount, or accidentally doubling up by giving two products that both contain diphenhydramine. Many combination cold medicines include it alongside other active ingredients, making it easy to overdose a child without realizing it.
Better Alternatives Exist
Second-generation antihistamines like loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) were specifically designed to treat allergies without crossing into the brain. They control histamine responses in the nose, skin, and airways while largely staying out of your central nervous system. This means far less sedation, no anticholinergic side effects, and no known link to cognitive decline with long-term use.
Interestingly, a meta-analysis comparing diphenhydramine to these newer drugs found that the sedation difference, while real, was more variable than expected. In some trials, diphenhydramine at a standard 50-mg dose didn’t produce significantly more impairment than the newer options. But the anticholinergic burden, the cardiac risks at higher doses, and the long-term cognitive concerns remain unique to first-generation drugs like Benadryl. The sedation comparison is only one piece of the picture.
For allergies, a second-generation antihistamine is the straightforward swap. For sleep, the options are more nuanced, but the short version is that diphenhydramine tolerance develops so quickly that it stops being effective within days, making it a poor long-term choice regardless of safety concerns.